The old saying nothing comes easy in life
The FDA approved another version of the injectable semaglutide, Wegovy, specifically to help people with obesity or who are overweight and have a weight-related medical condition
2 For a complete list of potential side effects, visit: What happens if you miss a dose of GLP-1
Retatrutide is the unimolecular triple agonist furthest in development and data from phase 2 trials suggests that this may soon become the most potent weight-lowering pharmacotherapy to be licenced
Unlike regular sugar (sucrose), which provides 4 kcal per gram, allulose provides only about 0.2 to 0.4 kcal per gram
Weekly semaglutide keeps receptors bathed in GLP-1 signals around the clock, trimming appetite so sharply that many patients push half-eaten plates aside and still reach double-digit weight-loss percentages